These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE). Gold MR; Daubert JC; Abraham WT; Hassager C; Dinerman JL; Hudnall JH; Cerkvenik J; Linde C Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1163-8. PubMed ID: 24125796 [TBL] [Abstract][Full Text] [Related]
4. Cardiac resynchronization therapy in heart failure patients: an update. Jeevanantham V; Daubert JP; Zareba W Cardiol J; 2009; 16(3):197-209. PubMed ID: 19437393 [TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of cardiac resynchronization therapy in patients with severe congestive heart failure. Davis DR; Krahn AD; Tang AS; Lemery R; Green MS; Gollob M; Yee R; Skanes AC; Klein GJ; Birnie DH Can J Cardiol; 2005 Apr; 21(5):413-7. PubMed ID: 15861258 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction). Linde C; Mealing S; Hawkins N; Eaton J; Brown B; Daubert JC; Eur Heart J; 2011 Jul; 32(13):1631-9. PubMed ID: 21112898 [TBL] [Abstract][Full Text] [Related]
8. Which patients with chronic heart failure should be referred for CRT-D implantation? Practical implications of current clinical research. Zareba W; Zareba KM Pol Arch Med Wewn; 2010 Mar; 120(3):95-102. PubMed ID: 20332716 [TBL] [Abstract][Full Text] [Related]
9. Cardiac resynchronization therapy reduces the risk of cardiac events in patients with diabetes enrolled in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT). Martin DT; McNitt S; Nesto RW; Rutter MK; Moss AJ Circ Heart Fail; 2011 May; 4(3):332-8. PubMed ID: 21350054 [TBL] [Abstract][Full Text] [Related]
10. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Abraham WT; Young JB; León AR; Adler S; Bank AJ; Hall SA; Lieberman R; Liem LB; O'Connell JB; Schroeder JS; Wheelan KR; Circulation; 2004 Nov; 110(18):2864-8. PubMed ID: 15505095 [TBL] [Abstract][Full Text] [Related]
11. Cardiac resynchronization therapy: a review of CRT-D versus CRT-P. Stabile G; Iuliano A; Turco P; Ciardiello C; De Simone A Future Cardiol; 2009 Nov; 5(6):567-72. PubMed ID: 19886783 [TBL] [Abstract][Full Text] [Related]
12. The European Cardiac Resynchronization Therapy Survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades. Bogale N; Witte K; Priori S; Cleland J; Auricchio A; Gadler F; Gitt A; Limbourg T; Linde C; Dickstein K; Eur J Heart Fail; 2011 Sep; 13(9):974-83. PubMed ID: 21771823 [TBL] [Abstract][Full Text] [Related]
13. [Commentary on the 2010 ESC guidelines on device therapy in heart failure ]. Israel CW; Anker SD; Hasenfuss G; Herzschrittmacherther Elektrophysiol; 2012 Mar; 23(1):33-7. PubMed ID: 22456701 [TBL] [Abstract][Full Text] [Related]
14. Mortality reduction of cardiac resynchronization and implantable cardioverter-defibrillator therapy in heart failure: an updated meta-analysis. Does recent evidence change the standard of care? Bertoldi EG; Polanczyk CA; Cunha V; Ziegelmann PK; Beck-da-Silva L; Rohde LE J Card Fail; 2011 Oct; 17(10):860-6. PubMed ID: 21962425 [TBL] [Abstract][Full Text] [Related]
15. Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF. Wilcox JE; Fonarow GC; Zhang Y; Albert NM; Curtis AB; Gheorghiade M; Heywood JT; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW Circ Heart Fail; 2014 Jan; 7(1):146-53. PubMed ID: 24178311 [TBL] [Abstract][Full Text] [Related]
16. Dyssynchrony, contractile function, and response to cardiac resynchronization therapy. Knappe D; Pouleur AC; Shah AM; Cheng S; Uno H; Hall WJ; Bourgoun M; Foster E; Zareba W; Goldenberg I; McNitt S; Pfeffer MA; Moss AJ; Solomon SD; Circ Heart Fail; 2011 Jul; 4(4):433-40. PubMed ID: 21602574 [TBL] [Abstract][Full Text] [Related]
17. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study. De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768 [TBL] [Abstract][Full Text] [Related]
18. Whom should I refer in 2014 for cardiac resynchronization? Manlucu J; Tang AS Can J Cardiol; 2014 Jun; 30(6):675-8. PubMed ID: 24882541 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of implantable cardioverter defibrillators and cardiac resynchronization therapy in heart failure. Freeman JV; Masoudi FA Heart Fail Clin; 2013 Jan; 9(1):59-77. PubMed ID: 23168318 [TBL] [Abstract][Full Text] [Related]
20. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure. Herweg B; Ilercil A; Cutro R; Dewhurst R; Krishnan S; Weston M; Barold SS Am J Cardiol; 2007 Jul; 100(1):90-3. PubMed ID: 17599447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]